000 01223 a2200313 4500
005 20250517080512.0
264 0 _c20160620
008 201606s 0 0 eng d
022 _a1469-493X
024 7 _a10.1002/14651858.CD005370.pub3
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAllingstrup, Mikkel
245 0 0 _aAntithrombin III for critically ill patients.
_h[electronic resource]
260 _bThe Cochrane database of systematic reviews
_cFeb 2016
300 _aCD005370 p.
_bdigital
500 _aPublication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review; Systematic Review
650 0 4 _aAnti-Inflammatory Agents
_xadverse effects
650 0 4 _aAnticoagulants
_xadverse effects
650 0 4 _aAntithrombin III
_xadverse effects
650 0 4 _aCritical Illness
_xmortality
650 0 4 _aHumans
650 0 4 _aRandomized Controlled Trials as Topic
700 1 _aWetterslev, Jørn
700 1 _aRavn, Frederikke B
700 1 _aMøller, Ann Merete
700 1 _aAfshari, Arash
773 0 _tThe Cochrane database of systematic reviews
_gvol. 2
_gp. CD005370
856 4 0 _uhttps://doi.org/10.1002/14651858.CD005370.pub3
_zAvailable from publisher's website
999 _c25715070
_d25715070